# K072035: Resolve Uvb Phototherapy System

- Pathway: 510(k) (Traditional)
- Applicant: Allux Medical
- Decided: Oct 16, 2007 after 83 days
- Product code: FTC (Light, Ultraviolet, Dermatological)
- Device class: 2
- Regulation: 21 CFR 878.4630
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K885026 (1989). 17 ancestors in all.
6 later devices descend from it; 1 cites it directly.
0 of 24 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K020591: Bclear, Lumenis (2002) Summary page 1.
- K022165: Theralight UV120-2 Uva/Uvb Phototherapy System, Model UV120-2, Theralight, Inc. (2002) Summary page 1.
- K022196: Natus Blue Light Phototherapy Unit, Natus Medical, Inc. (2002) Summary page 1.
- K070180: Wallaby 4, Respironics Inc., Sleep & Home Respiratory Group (2007) Summary page 1.

## Most influential descendants
- K170489: Skylit Phototherapy System (2017), 5 descendants of its own
- K173436: Luma Light System (2018), 3 descendants of its own
- K192642: 308nm Excimer System (2020), 2 descendants of its own
- K200971: 308nm Excimer System (2020), 1 descendant of its own
- K253871: Klär Lite (RCW-KL1000) (2026), 0 descendants of its own

## Indications for use
The ResolveTM UVB Phototherapy System is an ultraviolet light emitting medical device for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), and seborrheic dermatitis. The ResolveTM UVB Phototherapy System is intended to be used with all Skin Types (I - VI).

Source page: https://510kreport.com/device/K072035
Methodology: https://510kreport.com/methodology